NTRB Quote, Financials, Valuation and Earnings

NeuroOne Medical Technologies Corp. has a net margin of -321.33% compared to Nutriband, Inc.'s net margin of -88.5%. Nutriband, Inc.'s return on equity of -117.44% beat NeuroOne Medical Technologies Corp.'s return on equity of -166.02%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 196.44%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 231.6%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Nutriband, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Nutriband, Inc..

Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.

Nutriband, Inc. quarterly revenues are $622.5K, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $1.7M. Nutriband, Inc.'s net income of -$2M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.5M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 21.85x versus 2.45x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.

enVVeno Medical Corp. has a net margin of -321.33% compared to Nutriband, Inc.'s net margin of --. Nutriband, Inc.'s return on equity of -117.44% beat enVVeno Medical Corp.'s return on equity of -57.7%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 196.44%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3121.65%. Given that enVVeno Medical Corp. has higher upside potential than Nutriband, Inc., analysts believe enVVeno Medical Corp. is more attractive than Nutriband, Inc..

Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.063, suggesting its more volatile than the S&P 500 by 6.264%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.

Nutriband, Inc. quarterly revenues are $622.5K, which are larger than enVVeno Medical Corp. quarterly revenues of --. Nutriband, Inc.'s net income of -$2M is higher than enVVeno Medical Corp.'s net income of -$4.5M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 21.85x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Phibro Animal Health Corp. has a net margin of -321.33% compared to Nutriband, Inc.'s net margin of 7.29%. Nutriband, Inc.'s return on equity of -117.44% beat Phibro Animal Health Corp.'s return on equity of 24.77%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 196.44%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 5.47%. Given that Nutriband, Inc. has higher upside potential than Phibro Animal Health Corp., analysts believe Nutriband, Inc. is more attractive than Phibro Animal Health Corp..

Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.18% to investors and pays a quarterly dividend of $0.12 per share. Nutriband, Inc. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Nutriband, Inc. quarterly revenues are $622.5K, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. Nutriband, Inc.'s net income of -$2M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while Phibro Animal Health Corp.'s PE ratio is 24.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 21.85x versus 1.19x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.

SINTX Technologies, Inc. has a net margin of -321.33% compared to Nutriband, Inc.'s net margin of -1701.44%. Nutriband, Inc.'s return on equity of -117.44% beat SINTX Technologies, Inc.'s return on equity of -208.36%.

Nutriband, Inc. has a consensus price target of $15.00, signalling upside risk potential of 196.44%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $16.75 which suggests that it could grow by 336.2%. Given that SINTX Technologies, Inc. has higher upside potential than Nutriband, Inc., analysts believe SINTX Technologies, Inc. is more attractive than Nutriband, Inc..

Nutriband, Inc. has a beta of 1.907, which suggesting that the stock is 90.735% more volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.633, suggesting its less volatile than the S&P 500 by 36.717%.

Nutriband, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.

Nutriband, Inc. quarterly revenues are $622.5K, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. Nutriband, Inc.'s net income of -$2M is higher than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Nutriband, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband, Inc. is 21.85x versus 6.51x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.